User login
A Best Practices supplement to Skin & Allergy News and supported by Ranbaxy.
This supplement has been designed to meet the educational needs of Dermatologists and other Clinicians relative to the diagnosis and treatment of minimizing topical corticosteroid-induced cutaneous side effects.
Robert M. Lavker, PhD
Professor of Dermatology
and Director of
Dermatology Research
Department of Dermatology
Feinberg School of Medicine
Northwestern University
Chicago, Illinois
Mark Lebwohl, MD
Professor and Chairman
Department of Dermatology
The Mount Sinai School
of Medicine
New York, New York
Copyright © 2008 Elsevier Inc.
A Best Practices supplement to Skin & Allergy News and supported by Ranbaxy.
This supplement has been designed to meet the educational needs of Dermatologists and other Clinicians relative to the diagnosis and treatment of minimizing topical corticosteroid-induced cutaneous side effects.
Robert M. Lavker, PhD
Professor of Dermatology
and Director of
Dermatology Research
Department of Dermatology
Feinberg School of Medicine
Northwestern University
Chicago, Illinois
Mark Lebwohl, MD
Professor and Chairman
Department of Dermatology
The Mount Sinai School
of Medicine
New York, New York
Copyright © 2008 Elsevier Inc.
A Best Practices supplement to Skin & Allergy News and supported by Ranbaxy.
This supplement has been designed to meet the educational needs of Dermatologists and other Clinicians relative to the diagnosis and treatment of minimizing topical corticosteroid-induced cutaneous side effects.
Robert M. Lavker, PhD
Professor of Dermatology
and Director of
Dermatology Research
Department of Dermatology
Feinberg School of Medicine
Northwestern University
Chicago, Illinois
Mark Lebwohl, MD
Professor and Chairman
Department of Dermatology
The Mount Sinai School
of Medicine
New York, New York
Copyright © 2008 Elsevier Inc.
